Related Experiment Video
Updated: May 13, 2025

Meta-Analysis of the Effectiveness and Safety of Shugan Jieyu Capsules for the Treatment of Insomnia
Published on: February 17, 2023
Clinical Efficacy of Sleep Induction Intervention in Conjunction with Lorazepam in Managing Insomnia Disorder
Jing Chen1, Yan Zhang1, Guoqing Min1
1Department of Clinical Psychology, Lishui Second People's Hospital, Zhejiang Province, China.
Background:
This study investigates the clinical efficacy of a combined treatment approach involving sleep induction intervention and lorazepam in managing insomnia disorder.
Methods:
This study enrolled a sample of 150 individuals diagnosed with insomnia disorder, consecutively admitted to our clinic from June 2021 to June 2023. Following randomization, the participants were divided into 2 groups: observation and control groups. Both groups were administered lorazepam treatment, with the observation group receiving sleep induction intervention and the control group receiving routine nursing. After the 4-week treatment period, relevant observation indicators were assessed to evaluate the efficacy of sleep improvement in both patient intervention groups.
Results:
Compared to the control group that received only lorazepam treatment, the observation group, who underwent sleep induction intervention, showed a better treatment effectiveness rate, sleep quality, and psychological state regarding the treatment of sleep disorders (P < .05).
Conclusion:
Sleep induction intervention can improve the overall treatment effectiveness rate of sleep disorders, enhance sleep quality, and alleviate symptoms of anxiety and depression.
More Related Videos
07:54Drug-Induced Sleep Endoscopy DISE with Target Controlled Infusion TCI and Bispectral Analysis in Obstructive Sleep Apnea
Published on: December 6, 2016
08:49Assessing Changes in Volatile General Anesthetic Sensitivity of Mice after Local or Systemic Pharmacological Intervention
Published on: October 16, 2013
Related Concept Videos
Management of Insomnia
CNS Depressants: Barbiturates and Benzodiazepines
Sedatives and Hypnotics Drugs: Miscellaneous Agents
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
Sedatives and Hypnotics: Overview
Sedative-hypnotics are categorized into barbiturates, benzodiazepines (BZDs), and non-benzodiazepines or Z-drugs. These drugs work by suppressing central nervous system activity, and this suppression is dose-dependent. Older sedative medications, like barbiturates, follow a linear curve in...
Insomnia
Multiple factors contribute...
Sedatives and Hypnotics Drugs: Benzodiazepines
Benzodiazepines work by enhancing the effects of the inhibitory neurotransmitter GABA. They bind to the GABAA receptor, increasing its affinity for GABA, which opens chloride...